Table 1 Characteristics of study participants
Patients (n = 134) | |
|---|---|
Age (years) | 54.59 ± 13.78 |
BMI (kg/m2) | 23.70 ± 3.29 |
TG (mmol/L) | 1.46 (1.03, 2.06) |
TC (mmol/L) | 4.42 (3.88, 5.27) |
LDL-C (mmol/L) | 2.83 (2.36, 3.55) |
HDL-C (mmol/L) | 1.12 (0.96, 1.29) |
RC (mmol/L) | 0.43 (0.32, 0.56) |
Lp (a) (mg/L) | 174.70 (76.33, 382.10) |
NEFA (mmol/L) | 0.35 (0.25, 0.52) |
APO-A1 (g/L) | 1.02 ± 0.17 |
APO-B (g/L) | 0.77 (0.65, 0.97) |
WBCC (109/L) | 6.45 (5.34, 7.72) |
ALT (μ/L) | 17.20 (12.60, 25.38) |
AST (μ/L) | 17.70 (15.40, 25.10) |
Albumin (g/L) | 38.60 (37.05, 40.93) |
Creatinine (μmol/L) | 70.00 (59.00, 85.23) |
UA (μmol/L) | 316.00 (260.50, 382.50) |
Calcium (mmol/L) | 2.19 (2.12, 2.28) |
Fibrinogen (g/L) | 3.35 (2.90, 4.00) |
D-dimer (μg/mL) | 0.26 (0.20, 0.42) |
Hs-TNT (pg/mL) | 10.44 (5.33, 29.21) |
NT-proBNP (pg/mL) | 174.00 (52.45, 1008.00) |
sASGR1 (ng/mL) | 2.49 (1.71, 4.11) |
Sex | N (%) |
Male | 64 (47.76%) |
Female | 70 (52.24%) |
Statin use | |
No | 74 (55.22%) |
Yes | 60 (44.78%) |
Smoke | |
No | 93 (69.40%) |
Yes | 41 (30.60%) |
AMI | |
No | 113 (84.33%) |
Yes | 21 (15.67%) |
CAD | |
No | 50 (37.31%) |
Yes | 84 (62.69%) |
T2DM | |
No | 102 (76.12%) |
Yes | 32 (23.88%) |
Hypertension | |
No | 71 (52.99%) |
Yes | 63 (47.01%) |